RAPP — Rapport Therapeutics Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareSpeculativeSmall CapNeutral

Annual balance sheet for Rapport Therapeutics, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	—	—	—
Source:	PROSPECTUS	PROSPECTUS	10-K
Standards:	USG	USG	USG
Status:	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	31.2	147	305
Prepaid Expenses
Total Other Current Assets
Total Current Assets	31.3	151	310
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	0.335	4	4.97
Other Long Term Assets
Total Assets	31.6	155	315
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Total Other Current Liabilities
Total Current Liabilities	1.66	8.8	8.77
Long Term Debt
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	12.1	14.5	9.51
Non Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	19.5	141	305
Total Liabilities & Shareholders' Equity	31.6	155	315
Total Common Shares Outstanding